Dr. Martens plc (LON:DOCS – Get Free Report) insider Kenny Wilson bought 199 shares of the stock in a transaction dated Wednesday, December 11th. The stock was acquired at an average price of GBX 76 ($0.96) per share, with a total value of £151.24 ($190.89).
Kenny Wilson also recently made the following trade(s):
- On Thursday, September 26th, Kenny Wilson acquired 30,000 shares of Dr. Martens stock. The stock was bought at an average price of GBX 55 ($0.69) per share, with a total value of £16,500 ($20,825.44).
Dr. Martens Trading Down 0.6 %
Shares of DOCS opened at GBX 76.55 ($0.97) on Friday. The firm has a market capitalization of £736.20 million, a PE ratio of 1,093.57, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. Dr. Martens plc has a 12-month low of GBX 49.32 ($0.62) and a 12-month high of GBX 100 ($1.26). The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 129.55. The stock’s fifty day simple moving average is GBX 59.81 and its 200-day simple moving average is GBX 67.37.
Dr. Martens Cuts Dividend
Dr. Martens Company Profile
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
See Also
- Five stocks we like better than Dr. Martens
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- CD Calculator: Certificate of Deposit Calculator
- Texas Instruments: The Old-School Tech Titan Still Delivering
- How to Calculate Inflation Rate
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.